首页 > 最新文献

F&S science最新文献

英文 中文
Skoochies and its component substances induced testicular damage and impaired sperm function via increased generation of reactive oxygen species and impairment of the glutathione system in rats Skoochies 及其成分物质通过增加活性氧的生成和损害谷胱甘肽系统,导致大鼠睾丸损伤和精子功能受损。
Pub Date : 2024-11-01 DOI: 10.1016/j.xfss.2024.07.005
Ayodeji Folorunsho Ajayi Ph.D. , Olufemi Ogundeji Ogundipe M.Tech. , Moses Agbomhere Hamed B.M.L.S. , David Tolulope Oluwole M.Phil.

Objective

To examine the effect of skoochies, an illicit cocktail drink, on testicular and sperm function in male rats.

Design

Twenty-five adult male Wistar rats were assigned randomly into five groups (n = 5) as follows: normal saline; skoochies; Cannabis sativa; codeine; and tramadol. The cocktail (skoochies) used in this study was formulated with the following composition: codeine (5 mg/kg); tramadol (20 mg/kg); and cannabis extract (2 mg/kg). These doses are as previously reported. Administration was performed once daily for 28 days.

Setting

University.

Animal(s)

Twenty-five (25) male Wistar rats.

Intervention(s)

Skoochies, tramadol, Codeiene, Cannabis.

Main Outcome Measure(s)

Skoochies and its components induced testicular and sperm damage via increased generation of reactive oxygen species and impairment of glutathione system in rats.

Result(s)

Skoochies increased reactive oxygen species generation and impaired the antioxidant system resulting in inflammation that eventually damaged the testicular tissue. Skoochies caused oxidoinflammatory injury to this tissue, leading to impaired testicular function. This was evident by the distorted cytoarchitecture, reduced sperm count and motility, and impaired testicular deoxyribonucleic acid integrity.

Conclusion(s)

Thus, our results infer that skoochies impaired the testicular and sperm function through the increased generation of reactive oxygen species and impairment of the glutathione system.
研究目的研究非法鸡尾酒饮料 Skoochies 对雄性大鼠睾丸和精子功能的影响:将 25 只成年雄性 Wistar 大鼠随机分为以下 5 组(n = 5):正常生理盐水(NS 组)、skoochies(SK 组)、大麻(CS 组)、可待因(CO 组)和曲马多(TM 组)。本研究使用的鸡尾酒(skoochies)由以下成分配制而成:可待因(5 毫克/千克)、曲马多(20 毫克/千克)和大麻提取物(2 毫克/千克)。这些剂量与之前报告的剂量相同。每天给药一次,持续二十八(28)天:结果:Skoochies 增加了活性氧的生成,损害了抗氧化系统,导致炎症,最终损害了睾丸组织。Skoochies 对睾丸组织造成氧化-炎症损伤,导致睾丸功能受损。这表现在细胞结构扭曲、精子数量减少、活力降低以及睾丸 DNA 完整性受损等方面:因此,我们的研究结果推断,Skoochies 通过增加活性氧的生成和损害谷胱甘肽系统,导致睾丸和精子功能受损。
{"title":"Skoochies and its component substances induced testicular damage and impaired sperm function via increased generation of reactive oxygen species and impairment of the glutathione system in rats","authors":"Ayodeji Folorunsho Ajayi Ph.D. ,&nbsp;Olufemi Ogundeji Ogundipe M.Tech. ,&nbsp;Moses Agbomhere Hamed B.M.L.S. ,&nbsp;David Tolulope Oluwole M.Phil.","doi":"10.1016/j.xfss.2024.07.005","DOIUrl":"10.1016/j.xfss.2024.07.005","url":null,"abstract":"<div><h3>Objective</h3><div>To examine the effect of skoochies, an illicit cocktail drink, on testicular and sperm function in male rats.</div></div><div><h3>Design</h3><div>Twenty-five adult male Wistar rats were assigned randomly into five groups (n = 5) as follows: normal saline; skoochies; <em>Cannabis sativa</em>; codeine; and tramadol. The cocktail (skoochies) used in this study was formulated with the following composition: codeine (5 mg/kg); tramadol (20 mg/kg); and cannabis extract (2 mg/kg). These doses are as previously reported. Administration was performed once daily for 28 days.</div></div><div><h3>Setting</h3><div>University.</div></div><div><h3>Animal(s)</h3><div>Twenty-five (25) male Wistar rats.</div></div><div><h3>Intervention(s)</h3><div>Skoochies, tramadol, Codeiene, Cannabis.</div></div><div><h3>Main Outcome Measure(s)</h3><div>Skoochies and its components induced testicular and sperm damage via increased generation of reactive oxygen species and impairment of glutathione system in rats.</div></div><div><h3>Result(s)</h3><div>Skoochies increased reactive oxygen species generation and impaired the antioxidant system resulting in inflammation that eventually damaged the testicular tissue. Skoochies caused oxidoinflammatory injury to this tissue, leading to impaired testicular function. This was evident by the distorted cytoarchitecture, reduced sperm count and motility, and impaired testicular deoxyribonucleic acid integrity.</div></div><div><h3>Conclusion(s)</h3><div>Thus, our results infer that skoochies impaired the testicular and sperm function through the increased generation of reactive oxygen species and impairment of the glutathione system.</div></div>","PeriodicalId":73012,"journal":{"name":"F&S science","volume":"5 4","pages":"Pages 318-330"},"PeriodicalIF":0.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141617716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prostaglandin E2 regulates the plasminogen activator pathway in human endometrial endothelial cells: a new in vitro model to investigate heavy menstrual bleeding PGE2调节人子宫内膜内皮细胞中的血浆酶原激活剂通路:研究月经过多的新体外模型。
Pub Date : 2024-11-01 DOI: 10.1016/j.xfss.2024.07.007
Seifeldin Sadek M.D. , Terry A. Jacot Ph.D. , Diane M. Duffy Ph.D. , David F. Archer M.D.

Objective

To study the role of PGE2 in regulating plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator (tPA) in human primary endometrial endothelial cells (HEECs) from women with normal menstrual bleeding (NMB) and heavy menstrual bleeding (HMB).

Design

In vitro study using endometrial endothelial cells.

Setting

Research laboratory setting.

Patients

Women with NMB and HMB provided endometrial biopsy samples.

Interventions

Prostaglandin E2 and PGE2 receptor-selective agonists were administered to cultured HEECs.

Main Outcome Measures

Levels of PAI-1 and tPA in NMB-HEECs and HMB-HEECs after treatment with PGE2 and receptor-selective agonists.

Results

Prostaglandin E2 increased total PAI-1 levels in NMB-HEECs, but not in HMB-HEECs, which had higher baseline PAI-1 levels. PGE2 receptors (PTGER)1 and PTGER2 agonists increased PAI-1 in NMB-HEECs, whereas PTGER3 and PTGER4 did not. Prostaglandin E2 had no effect on tPA levels in either NMB-HEECs or HMB-HEECs.

Conclusions

Prostaglandin E2, through PTGER1 and PTGER2, regulates the plasminogen activator system in NMB-HEECs, suggesting a role in reducing fibrinolytic activity during normal menstrual cycles. The lack of PGE2 effect and elevated baseline PAI-1 in HMB-HEECs support using this in vitro model to further understand prostaglandin pathways in NMB and HMB.
目的研究 PGE2 在调节正常月经出血(NMB)和大量月经出血(HMB)妇女的人原代子宫内膜内皮细胞(HEECs)中的纤溶酶原激活物抑制剂-1(PAI-1)和组织纤溶酶原激活物(tPA)中的作用:设计:使用子宫内膜内皮细胞进行体外研究:研究实验室环境:正常月经出血(NMB)和大量月经出血(HMB)妇女提供子宫内膜活检样本:干预措施:向培养的 HEECs 施用 PGE2 和 PGE2 受体选择性激动剂:PGE2和受体选择性激动剂治疗后,NMB-HEECs和HMB-HEECs中PAI-1和tPA的水平:结果:PGE2 增加了 NMB-HEECs 的总 PAI-1 水平,但没有增加 HMB-HEECs 的总 PAI-1 水平,后者的基线 PAI-1 水平更高。PTGER1 和 PTGER2 激动剂会增加 NMB-HEECs 中的 PAI-1,而 PTGER3 和 PTGER4 不会。PGE2 对 NMB-HEECs 或 HMB-HEECs 中的 tPA 水平均无影响:结论:PGE2 通过 PTGER1 和 PTGER2 调节 NMB-HEECs 中的纤溶酶原激活剂系统,这表明它在正常月经周期中降低了纤溶活性。HMB-HEECs 中缺乏 PGE2 作用且基线 PAI-1 升高,这支持使用这种体外模型来进一步了解正常和大量月经出血中的前列腺素通路。
{"title":"Prostaglandin E2 regulates the plasminogen activator pathway in human endometrial endothelial cells: a new in vitro model to investigate heavy menstrual bleeding","authors":"Seifeldin Sadek M.D. ,&nbsp;Terry A. Jacot Ph.D. ,&nbsp;Diane M. Duffy Ph.D. ,&nbsp;David F. Archer M.D.","doi":"10.1016/j.xfss.2024.07.007","DOIUrl":"10.1016/j.xfss.2024.07.007","url":null,"abstract":"<div><h3>Objective</h3><div>To study the role of PGE<sub>2</sub> in regulating plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator (tPA) in human primary endometrial endothelial cells (HEECs) from women with normal menstrual bleeding (NMB) and heavy menstrual bleeding (HMB).</div></div><div><h3>Design</h3><div>In vitro study using endometrial endothelial cells.</div></div><div><h3>Setting</h3><div>Research laboratory setting.</div></div><div><h3>Patients</h3><div>Women with NMB and HMB provided endometrial biopsy samples.</div></div><div><h3>Interventions</h3><div>Prostaglandin E<sub>2</sub> and PGE<sub>2</sub> receptor-selective agonists were administered to cultured HEECs.</div></div><div><h3>Main Outcome Measures</h3><div>Levels of PAI-1 and tPA in NMB-HEECs and HMB-HEECs after treatment with PGE<sub>2</sub> and receptor-selective agonists.</div></div><div><h3>Results</h3><div>Prostaglandin E<sub>2</sub> increased total PAI-1 levels in NMB-HEECs, but not in HMB-HEECs, which had higher baseline PAI-1 levels. PGE<sub>2</sub> receptors (PTGER)1 and PTGER2 agonists increased PAI-1 in NMB-HEECs, whereas PTGER3 and PTGER4 did not. Prostaglandin E<sub>2</sub> had no effect on tPA levels in either NMB-HEECs or HMB-HEECs.</div></div><div><h3>Conclusions</h3><div>Prostaglandin E<sub>2</sub>, through PTGER1 and PTGER2, regulates the plasminogen activator system in NMB-HEECs, suggesting a role in reducing fibrinolytic activity during normal menstrual cycles. The lack of PGE<sub>2</sub> effect and elevated baseline PAI-1 in HMB-HEECs support using this in vitro model to further understand prostaglandin pathways in NMB and HMB.</div></div>","PeriodicalId":73012,"journal":{"name":"F&S science","volume":"5 4","pages":"Pages 379-385"},"PeriodicalIF":0.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141749911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oligoasthenospermia is correlated with increased preeclampsia incidence in subfertile couples undergoing in vitro fertilization and embryo transfer: a secondary analysis of a randomized clinical trial 在接受体外受精和胚胎移植(IVF-ET)的不育夫妇中,少精子症与子痫前期发病率增加有关:随机临床试验的二次分析。
Pub Date : 2024-11-01 DOI: 10.1016/j.xfss.2024.08.003
Ling Guo M.D. , Anliang Guo Ph.D. , Xiangxin Lan M.D. , Siqi Tian M.S. , Fengxuan Sun M.D. , Yaxin Su M.S. , Zi-Jiang Chen M.D., Ph.D. , Yongzhi Cao Ph.D. , Yan Li M.D., Ph.D.

Objective

To evaluate whether intergroup differences in the risk of maternal pregnancy complications after in vitro fertilization (IVF) vary with male factor.

Design

A post hoc exploratory secondary analysis of data from a multicenter, randomized, controlled noninferiority trial (NCT03118141).

Setting

Academic fertility centers.

Patient(s)

A total of 1,131 subfertile women with complete recording of their male partner’s semen parameters during the trial were enrolled. All participants underwent intracytoplasmic sperm injection followed by frozen embryo transfer (ET) as part of their assisted reproductive technology treatment protocol.

Intervention(s)

Women were divided into the oligoasthenospermia (n = 405) and normospermia (n = 726) groups according to the quality of male sperm.

Main Outcome Measure(s)

Pregnancy complications, principally including the incidence of preeclampsia.

Result(s)

Notably, we found that the risk of maternal preeclampsia was significantly higher in the oligoasthenospermia group than in the normospermia group. After adjustments for confounding factors by multivariate logistic regression analysis, the incidence of preeclampsia in the oligoasthenospermia group was still significantly higher than that in the normospermia group (6.55% vs. 3.60%; odds ratio, 0.529; 95% confidence interval, 0.282–0.992). However, there were no significant differences in terms of embryo quality, cumulative live birth rate, other pregnancy complications, or neonatal outcomes between the 2 groups.

Conclusion(s)

Oligoasthenospermia was associated with a higher risk of maternal preeclampsia in subfertile couples undergoing IVF-ET treatment. In clinical practice, it is essential to thoroughly evaluate the sperm quality and quantity of male partners before IVF-ET. Further research is needed to establish the causal relationships between semen quality and adverse pregnancy complications, particularly preeclampsia, and explore potential interventions.
目的评估体外受精(IVF)后母体妊娠并发症风险的组间差异是否因男性因素而异:对一项多中心、随机对照、非劣效试验(NCT03118141)的数据进行事后探索性二次分析:受试者共招募了 1131 名在试验期间完整记录了其男性伴侣精液参数的亚不育女性。作为辅助生殖技术(ART)治疗方案的一部分,所有参与者都接受了卵胞浆内单精子注射(ICSI)和冷冻胚胎移植(FET):干预措施:根据男性精子的质量将女性分为少弱精子症组(405人)和正常精子症组(726人):妊娠并发症,主要包括子痫前期的发生率:值得注意的是,我们发现少精症组产妇子痫前期的风险明显高于正常精子症组(P=0.035)。通过多变量逻辑回归分析调整混杂因素后,少精症组的子痫前期发生率仍明显高于正常精子症组(6.55% vs. 3.60%;OR=0.529;95% CI=0.282-0.992;P-adj=0.047)。然而,两组在胚胎质量、累积活产率、其他妊娠并发症或新生儿结局方面没有明显差异(P>0.05):结论:在接受IVF-ET治疗的亚育夫妇中,低精子症与较高的产妇子痫前期风险有关。在临床实践中,体外受精-胚胎移植前彻底评估男性伴侣的精子质量和数量至关重要。要确定精液质量与不良妊娠并发症(尤其是子痫前期)之间的因果关系,并探索潜在的干预措施,还需要进一步的研究。
{"title":"Oligoasthenospermia is correlated with increased preeclampsia incidence in subfertile couples undergoing in vitro fertilization and embryo transfer: a secondary analysis of a randomized clinical trial","authors":"Ling Guo M.D. ,&nbsp;Anliang Guo Ph.D. ,&nbsp;Xiangxin Lan M.D. ,&nbsp;Siqi Tian M.S. ,&nbsp;Fengxuan Sun M.D. ,&nbsp;Yaxin Su M.S. ,&nbsp;Zi-Jiang Chen M.D., Ph.D. ,&nbsp;Yongzhi Cao Ph.D. ,&nbsp;Yan Li M.D., Ph.D.","doi":"10.1016/j.xfss.2024.08.003","DOIUrl":"10.1016/j.xfss.2024.08.003","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate whether intergroup differences in the risk of maternal pregnancy complications after in vitro fertilization (IVF) vary with male factor.</div></div><div><h3>Design</h3><div>A post hoc exploratory secondary analysis of data from a multicenter, randomized, controlled noninferiority trial (NCT03118141).</div></div><div><h3>Setting</h3><div>Academic fertility centers.</div></div><div><h3>Patient(s)</h3><div>A total of 1,131 subfertile women with complete recording of their male partner’s semen parameters during the trial were enrolled. All participants underwent intracytoplasmic sperm injection followed by frozen embryo transfer (ET) as part of their assisted reproductive technology treatment protocol.</div></div><div><h3>Intervention(s)</h3><div>Women were divided into the oligoasthenospermia (n = 405) and normospermia (n = 726) groups according to the quality of male sperm.</div></div><div><h3>Main Outcome Measure(s)</h3><div>Pregnancy complications, principally including the incidence of preeclampsia.</div></div><div><h3>Result(s)</h3><div>Notably, we found that the risk of maternal preeclampsia was significantly higher in the oligoasthenospermia group than in the normospermia group. After adjustments for confounding factors by multivariate logistic regression analysis, the incidence of preeclampsia in the oligoasthenospermia group was still significantly higher than that in the normospermia group (6.55% vs. 3.60%; odds ratio, 0.529; 95% confidence interval, 0.282–0.992). However, there were no significant differences in terms of embryo quality, cumulative live birth rate, other pregnancy complications, or neonatal outcomes between the 2 groups.</div></div><div><h3>Conclusion(s)</h3><div>Oligoasthenospermia was associated with a higher risk of maternal preeclampsia in subfertile couples undergoing IVF-ET treatment. In clinical practice, it is essential to thoroughly evaluate the sperm quality and quantity of male partners before IVF-ET. Further research is needed to establish the causal relationships between semen quality and adverse pregnancy complications, particularly preeclampsia, and explore potential interventions.</div></div>","PeriodicalId":73012,"journal":{"name":"F&S science","volume":"5 4","pages":"Pages 386-394"},"PeriodicalIF":0.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141997010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A seed or soil problem in early endometriosis: stromal cell origin drives cellular invasion and coupling over mesothelial cell origin 早期子宫内膜异位症中的种子或土壤问题:基质细胞来源比间皮细胞来源更能驱动细胞入侵和耦合。
Pub Date : 2024-11-01 DOI: 10.1016/j.xfss.2024.08.001
Virginia-Arlene Go M.D. , Jeffery Chavez , Randal D. Robinson M.D. , Bruce J. Nicholson Ph.D.

Objective

To study the role of the mesothelial cells in early endometriosis lesion formation by assessing in vitro cell-to-cell communication and invasion of endometrial cells across a mesothelial cell monolayer, with both cell types derived from both patients with endometriosis and control patients.

Design

Laboratory-based experimental study.

Setting

University hospital and laboratory.

Patient(s)

Consenting reproductive-age women who underwent laparoscopy for gynecologic reasons and were confirmed to have either endometriosis with pathology tissue diagnosis (n = 8) or no endometriosis n = 8) at the time of surgery.

Intervention(s)

Primary stromal cells cultured from endometrial pipelle biopsies and primary mesothelial cells cultured from peritoneal explants were used in transmesothelial invasion assays and gap junction coupling assays.

Main Outcome Measure(s)

Comparison of potential for lesion formation, using in vitro models, of both primary endometrial and mesothelial cells from patients with endometriosis and control patients, establishing the former as the primary disease driver.

Result(s)

When comparing mesothelial cells from control patients with those from patients with endometriosis, there was no significant difference in the amount of stromal cell invasion across either barrier. In contrast, when comparing stromal cell origin, the amount of invasion by endometriosis stromal cells was greater than control stromal cells regardless of whether the mesothelial cell monolayer was derived from patients with the disease or control patients. Additionally, primary mesothelial cells induced more gap junction coupling, a requirement for invasion, in stromal cells from patients with endometriosis than control patients, again independent of mesothelial origin. The notable exception was mesothelial cells derived from endometriotic lesion-affected areas that showed depressed ability to support invasion.

Conclusion(s)

Although both endometrial and mesothelial cells need to function for establishment of endometriosis lesions, the endometrium seems to be the key player, serving as an ideal target for diagnostic strategies and therapeutic intervention. While this notion is consistent with previous studies, to our knowledge, we are the first to directly test both primary mesothelial and endometrial cells from patients with endometriosis and control patients to compare propensities for mesothelial invasion.
研究目的通过评估子宫内膜异位症患者和对照组患者的两种细胞类型的体外细胞间通讯和子宫内膜细胞侵入间皮细胞单层的情况,研究间皮细胞在早期子宫内膜异位症病变形成中的作用:设计:基于实验室的实验研究 设置:大学医院和实验室患者:同意接受腹腔镜妇科检查的育龄妇女,手术时经病理组织诊断确认患有子宫内膜异位症(8 人)或无子宫内膜异位症(8 人):利用子宫内膜管活检培养的原代基质细胞和腹膜外植体培养的原代间皮细胞进行跨间皮细胞侵袭试验和间隙连接试验。主要结果:利用体外模型比较子宫内膜异位症患者和对照组患者的原代子宫内膜细胞和间皮细胞形成病变的可能性,确定前者是主要的疾病驱动因素:结果:将对照组患者的间皮细胞与子宫内膜异位症患者的间皮细胞进行比较时,基质细胞跨屏障入侵的数量没有明显差异。相反,在比较基质细胞来源时,无论间皮细胞单层是来自疾病患者还是对照组患者,子宫内膜异位症基质细胞的侵袭量都大于对照组基质细胞。此外,原发性间皮细胞诱导子宫内膜异位症基质细胞的间隙连接(侵袭所需的条件)多于对照组患者,这同样与间皮细胞来源无关。值得注意的例外是,来自子宫内膜异位症病变影响区的间皮细胞支持侵袭的能力较低:结论:虽然子宫内膜和间皮细胞都需要发挥作用才能形成子宫内膜异位症病灶,但子宫内膜似乎是关键角色,是诊断策略和治疗干预的理想目标。这一观点与之前的研究一致,但我们是首次直接检测子宫内膜异位症患者和对照组患者的原始间皮细胞和子宫内膜细胞,以比较间皮细胞入侵的倾向。
{"title":"A seed or soil problem in early endometriosis: stromal cell origin drives cellular invasion and coupling over mesothelial cell origin","authors":"Virginia-Arlene Go M.D. ,&nbsp;Jeffery Chavez ,&nbsp;Randal D. Robinson M.D. ,&nbsp;Bruce J. Nicholson Ph.D.","doi":"10.1016/j.xfss.2024.08.001","DOIUrl":"10.1016/j.xfss.2024.08.001","url":null,"abstract":"<div><h3>Objective</h3><div>To study the role of the mesothelial cells in early endometriosis lesion formation by assessing in vitro cell-to-cell communication and invasion of endometrial cells across a mesothelial cell monolayer, with both cell types derived from both patients with endometriosis and control patients.</div></div><div><h3>Design</h3><div>Laboratory-based experimental study.</div></div><div><h3>Setting</h3><div>University hospital and laboratory.</div></div><div><h3>Patient(s)</h3><div>Consenting reproductive-age women who underwent laparoscopy for gynecologic reasons and were confirmed to have either endometriosis with pathology tissue diagnosis (n = 8) or no endometriosis n = 8) at the time of surgery.</div></div><div><h3>Intervention(s)</h3><div>Primary stromal cells cultured from endometrial pipelle biopsies and primary mesothelial cells cultured from peritoneal explants were used in transmesothelial invasion assays and gap junction coupling assays.</div></div><div><h3>Main Outcome Measure(s)</h3><div>Comparison of potential for lesion formation, using in vitro models, of both primary endometrial and mesothelial cells from patients with endometriosis and control patients, establishing the former as the primary disease driver.</div></div><div><h3>Result(s)</h3><div>When comparing mesothelial cells from control patients with those from patients with endometriosis, there was no significant difference in the amount of stromal cell invasion across either barrier. In contrast, when comparing stromal cell origin, the amount of invasion by endometriosis stromal cells was greater than control stromal cells regardless of whether the mesothelial cell monolayer was derived from patients with the disease or control patients. Additionally, primary mesothelial cells induced more gap junction coupling, a requirement for invasion, in stromal cells from patients with endometriosis than control patients, again independent of mesothelial origin. The notable exception was mesothelial cells derived from endometriotic lesion-affected areas that showed depressed ability to support invasion.</div></div><div><h3>Conclusion(s)</h3><div>Although both endometrial and mesothelial cells need to function for establishment of endometriosis lesions, the endometrium seems to be the key player, serving as an ideal target for diagnostic strategies and therapeutic intervention. While this notion is consistent with previous studies, to our knowledge, we are the first to directly test both primary mesothelial and endometrial cells from patients with endometriosis and control patients to compare propensities for mesothelial invasion.</div></div>","PeriodicalId":73012,"journal":{"name":"F&S science","volume":"5 4","pages":"Pages 395-403"},"PeriodicalIF":0.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141914743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The immune landscape of uterine fibroids as determined by mass cytometry 通过质控细胞仪确定子宫肌瘤的免疫格局
Pub Date : 2024-08-01 DOI: 10.1016/j.xfss.2024.06.004

Objective

To study the differences in immune cell profiles in uterine fibroids (Fibs) and matched myometrium (Myo).

Design

Observational study.

Setting

Laboratory study.

Patient(s)

The study included tissue that was collected from 10 pairs of Fib and matched Myo from women, not on hormonal medications, undergoing hysterectomy and myomectomy.

Intervention(s)

None.

Main Outcome Measure(s)

Differences in immune cell and cytokine composition between Fib and matched Myo.

Result(s)

The mass cytometry analysis indicated that Fibs had a significantly higher number of natural killer (NK) cells, total macrophages, M2 macrophages, and conventional dendritic cells when compared with matched Myo from the same patient. In contrast, Fibs had significantly fewer CD3 and CD4 T cells when compared with Myo. The mass cytometry analysis results did not show any significant difference in the number of resting mast cells. Immunoflurorescent and immunohistochemical imaging confirmed the cytometry by time of flight results, showing a significantly higher number of NK cells, tryptase-positive mast cells indicative of mast cell activation, total macrophages, and M2 cells in Fibs and a significantly lower number of CD3 and CD4 T cells. The cytokine assay revealed significantly increased levels of human interferon α2, interleukin (IL)-1α, and platelet-derived growth factor AA and significantly lower levels of macrophage colony-stimulating factor and IL-1 receptor antagonist in Fib.

Conclusion(s)

Our results show significant differences in immune cell populations and cytokine levels between Fib and Myo. These differences could account for the increased inflammation in fib and a potential mechanism by which these tumors evade the immune system. These findings provide a foundation for further studies exploring the role of immune cells in Fib development.

目的:研究子宫肌瘤(Fib)和匹配子宫肌层(Myo)免疫细胞谱的差异:研究子宫肌瘤(Fib)和匹配子宫肌瘤(Myo)免疫细胞谱的差异:观察性研究研究对象: 实验室研究研究包括从接受子宫切除术和子宫肌瘤剔除术的未服用激素药物的妇女的10对子宫肌瘤和匹配子宫肌层中收集的组织:主要结果测量:结果:质控细胞仪分析表明,与来自同一患者的匹配子宫肌瘤相比,子宫肌瘤的 NK 细胞、巨噬细胞总数、M2 巨噬细胞和传统树突状细胞数量明显较高。相比之下,子宫肌瘤的 CD3 和 CD4 T 细胞数量明显少于子宫肌层。质谱分析显示,静止肥大细胞的数量没有明显差异。IFC 和 IHC 成像证实了 CytoF 的结果,显示子宫肌瘤中的 CD3 和 CD4 T 细胞数量明显较高:我们的研究结果表明,Fib 和 Myo 的免疫细胞群和细胞因子水平存在明显差异。在 Fib 中,巨噬细胞、M2 巨噬细胞、NK 细胞和树突状细胞的总数明显增加,而 CD3 和 CD4 T 细胞则明显减少。IHC 证实静息肥大细胞总数无差异,但纤维中胰蛋白酶阳性肥大细胞明显增加。与匹配的子宫肌层相比,纤维的IFNA2、IL-1α和PDGF-AA水平明显更高,而IL-1RA和M-CSF水平明显更低。这些发现为进一步研究免疫细胞在纤维发育中的作用奠定了基础。
{"title":"The immune landscape of uterine fibroids as determined by mass cytometry","authors":"","doi":"10.1016/j.xfss.2024.06.004","DOIUrl":"10.1016/j.xfss.2024.06.004","url":null,"abstract":"<div><h3>Objective</h3><p>To study the differences in immune cell<span> profiles in uterine fibroids<span> (Fibs) and matched myometrium (Myo).</span></span></p></div><div><h3>Design</h3><p>Observational study.</p></div><div><h3>Setting</h3><p>Laboratory study.</p></div><div><h3>Patient(s)</h3><p><span>The study included tissue that was collected from 10 pairs of Fib and matched Myo from women, not on hormonal medications, undergoing hysterectomy and </span>myomectomy.</p></div><div><h3>Intervention(s)</h3><p>None.</p></div><div><h3>Main Outcome Measure(s)</h3><p>Differences in immune cell and cytokine composition between Fib and matched Myo.</p></div><div><h3>Result(s)</h3><p>The mass cytometry<span><span><span><span> analysis indicated that Fibs had a significantly higher number of natural killer (NK) cells, total macrophages, M2 macrophages<span>, and conventional dendritic cells when compared with matched Myo from the same patient. In contrast, Fibs had significantly fewer CD3<span> and CD4 T cells when compared with Myo. The mass </span></span></span>cytometry analysis results did not show any significant difference in the number of resting mast cells. Immunoflurorescent and immunohistochemical imaging confirmed the cytometry by time of flight results, showing a significantly higher number of NK cells, tryptase-positive mast cells indicative of mast </span>cell activation, total macrophages, and M2 cells in Fibs and a significantly lower number of CD3 and CD4 T cells. The cytokine assay revealed significantly increased levels of </span>human interferon<span> α2, interleukin (IL)-1α, and platelet-derived growth factor AA and significantly lower levels of macrophage colony-stimulating factor and IL-1 receptor antagonist in Fib.</span></span></p></div><div><h3>Conclusion(s)</h3><p>Our results show significant differences in immune cell populations and cytokine levels between Fib and Myo. These differences could account for the increased inflammation in fib and a potential mechanism by which these tumors evade the immune system. These findings provide a foundation for further studies exploring the role of immune cells in Fib development.</p></div>","PeriodicalId":73012,"journal":{"name":"F&S science","volume":"5 3","pages":"Pages 272-282"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141461201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characterizing the consistency of motion of spermatozoa through nanoscale motion tracing 通过纳米级运动追踪表征精子运动的一致性。
Pub Date : 2024-08-01 DOI: 10.1016/j.xfss.2024.07.002

Objective

To demonstrate nanoscale motion tracing of spermatozoa and present analysis of the motion traces to characterize the consistency of motion of spermatozoa as a complement to progressive motility analysis.

Design

Anonymized sperm samples were videographed under a quantitative phase microscope, followed by generating and analyzing superresolution motion traces of individual spermatozoa.

Setting

Not applicable.

Patient(s)

Centrifuged human sperm samples.

Intervention(s)

Not applicable.

Main Outcome Measure(s)

Precision of motion trace of individual sperms, presence of a helical pattern in the motion trace, mean and standard deviations of helical periods and radii of sperm motion traces, speed of progression.

Result(s)

Spatially sensitive quantitative phase imaging with a superresolution computational technique MUltiple SIgnal Classification ALgorithm allowed achieving motion precision of 340 nm using ×10, 0.25 numerical aperture lens whereas the diffraction-limited resolution at this setting was 1,320 nm. The motion traces thus derived facilitated new kinematic features of sperm, namely the statistics of helix period and radii per sperm.

Through the analysis, 47 sperms with a speed >25 μm/s were randomly selected from the same healthy donor semen sample, it is seen that the kinematic features did not correlate with the speed of the sperms. In addition, it is noted that spermatozoa may experience changes in the periodicity and radius of the helical path over time. Further, some very fast sperms (e.g., >70 μm/s) may demonstrate irregular motion and need further investigation.

Presented computational analysis can be used directly for sperm samples from both fertility patients with normal and abnormal sperm cell conditions.

We note that MUltiple SIgnal Classification ALgorithm is an image analysis technique that may vaguely fall under the machine learning category, but the conventional metrics for reporting found in Enhancing the QUAlity and Transparency Of health Research network do not apply. Alternative suitable metrics are reported, and bias is avoided through random selection of regions for analysis. Detailed methods are included for reproducibility.

Conclusion(s)

Kinematic features derived from nanoscale motion traces of spermatozoa contain information complementary to the speed of the sperms, allowing further distinction among the progressively motile sperms. Some highly progressive spermatozoa may have irregular motion patterns, and whether irregularity of motion indicates poor quality regarding artificial insemination needs further investigation. The presented technique can be generalized for sperm analysis for a variety of fertility conditions.

目的:展示精子的纳米级运动轨迹,并分析精子运动的一致性,作为渐进运动分析的补充:展示精子的纳米级运动轨迹,并对运动轨迹进行分析,以确定精子运动的一致性,作为渐进式运动分析的补充:设计:在定量相显微镜下对匿名精子样本进行录像,然后生成并分析单个精子的超分辨率运动轨迹:离心人类精子样本:主要结果指标:单个精子运动轨迹的精确度、运动轨迹中是否存在螺旋模式、精子运动轨迹螺旋周期和半径的平均值和标准偏差、运动速度:利用超分辨率计算技术MUltiple SIgnal Classification ALgorithm (MUSICAL)进行空间敏感定量相位成像,使用10×、0.25 NA镜头可实现340纳米的运动精度,而在此设置下的衍射极限分辨率为1320纳米。由此得出的运动轨迹有助于获得精子的新运动学特征,即每个精子的螺旋周期和半径统计。通过对从同一健康捐精者的精液样本中随机抽取的速度大于 25 μm/sec 的 47 个精子进行分析,发现运动学特征与精子的速度无关。此外,我们还注意到,精子的螺旋路径周期和半径可能会随着时间的推移而发生变化。此外,一些速度极快的精子(例如>70微米/秒)可能会表现出不规则运动,这需要进一步研究。所提出的计算分析可直接用于正常和异常精子细胞条件的生育患者的精子样本。我们注意到,MUSICAL 是一种图像分析技术,可能隐约属于机器学习范畴,但 EQUATOR 中的传统报告指标并不适用。我们报告了其他合适的指标,并通过随机选择分析区域来避免偏差。报告中还包含了详细的方法,以确保可重复性:从精子的纳米级运动轨迹中得出的运动学特征包含精子速度的补充信息,可进一步区分渐进运动的精子。一些高度渐进的精子可能具有不规则的运动模式,而运动的不规则性是否表明人工授精的质量不佳,还需要进一步研究。该技术可用于各种生育条件下的精子分析。
{"title":"Characterizing the consistency of motion of spermatozoa through nanoscale motion tracing","authors":"","doi":"10.1016/j.xfss.2024.07.002","DOIUrl":"10.1016/j.xfss.2024.07.002","url":null,"abstract":"<div><h3>Objective</h3><p>To demonstrate nanoscale motion tracing of spermatozoa and present analysis of the motion traces to characterize the consistency of motion of spermatozoa as a complement to progressive motility analysis.</p></div><div><h3>Design</h3><p>Anonymized sperm samples were videographed under a quantitative phase microscope, followed by generating and analyzing superresolution motion traces of individual spermatozoa.</p></div><div><h3>Setting</h3><p>Not applicable.</p></div><div><h3>Patient(s)</h3><p>Centrifuged human sperm samples.</p></div><div><h3>Intervention(s)</h3><p>Not applicable.</p></div><div><h3>Main Outcome Measure(s)</h3><p>Precision of motion trace of individual sperms, presence of a helical pattern in the motion trace, mean and standard deviations of helical periods and radii of sperm motion traces, speed of progression.</p></div><div><h3>Result(s)</h3><p>Spatially sensitive quantitative phase imaging with a superresolution computational technique MUltiple SIgnal Classification ALgorithm allowed achieving motion precision of 340 nm using ×10, 0.25 numerical aperture lens whereas the diffraction-limited resolution at this setting was 1,320 nm. The motion traces thus derived facilitated new kinematic features of sperm, namely the statistics of helix period and radii per sperm.</p><p>Through the analysis, 47 sperms with a speed &gt;25 μm/s were randomly selected from the same healthy donor semen sample, it is seen that the kinematic features did not correlate with the speed of the sperms. In addition, it is noted that spermatozoa may experience changes in the periodicity and radius of the helical path over time. Further, some very fast sperms (e.g., &gt;70 μm/s) may demonstrate irregular motion and need further investigation.</p><p>Presented computational analysis can be used directly for sperm samples from both fertility patients with normal and abnormal sperm cell conditions.</p><p>We note that MUltiple SIgnal Classification ALgorithm is an image analysis technique that may vaguely fall under the machine learning category, but the conventional metrics for reporting found in Enhancing the QUAlity and Transparency Of health Research network do not apply. Alternative suitable metrics are reported, and bias is avoided through random selection of regions for analysis. Detailed methods are included for reproducibility.</p></div><div><h3>Conclusion(s)</h3><p>Kinematic features derived from nanoscale motion traces of spermatozoa contain information complementary to the speed of the sperms, allowing further distinction among the progressively motile sperms. Some highly progressive spermatozoa may have irregular motion patterns, and whether irregularity of motion indicates poor quality regarding artificial insemination needs further investigation. The presented technique can be generalized for sperm analysis for a variety of fertility conditions.</p></div>","PeriodicalId":73012,"journal":{"name":"F&S science","volume":"5 3","pages":"Pages 215-224"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666335X24000375/pdfft?md5=151811c9750b1a0eee3853255e4320ec&pid=1-s2.0-S2666335X24000375-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141560463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From the Editor-in-Chief 主编的话
Pub Date : 2024-08-01 DOI: 10.1016/j.xfss.2024.07.003
{"title":"From the Editor-in-Chief","authors":"","doi":"10.1016/j.xfss.2024.07.003","DOIUrl":"10.1016/j.xfss.2024.07.003","url":null,"abstract":"","PeriodicalId":73012,"journal":{"name":"F&S science","volume":"5 3","pages":"Page 213"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141545588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Donor side effects experienced under minimal controlled ovarian stimulation with in vitro maturation vs. conventional controlled ovarian stimulation for in vitro fertilization treatment 在体外受精(IVF)治疗中,最小控制卵巢刺激(COS)和体外成熟(IVM)对传统 COS 的副作用。
Pub Date : 2024-08-01 DOI: 10.1016/j.xfss.2024.05.002

Objective

To evaluate oocyte retrieval experiences and side effects under minimally controlled ovarian stimulation (COS) treatment for in vitro maturation (IVM) of oocytes compared with conventional COS treatment.

Design

A retrospective survey study.

Setting

Clinical in vitro fertilization treatment center.

Patient(s)

Data were collected from subjects undergoing minimal COS treatment (n = 110; 600–800 IU follicle-stimulating hormone) for IVM of oocytes and conventional COS treatment for egg donation (n = 48; 1,800–2,600 IU follicle-stimulating hormone) from April 2022 to November 2023.

Intervention(s)

Minimal and conventional COS treatments.

Main Outcome Measure(s)

The most common side effects experienced during ovarian stimulation and after oocyte pick-up, satisfaction level, and the likelihood of recommending or repeating minimal or conventional COS. Statistical analysis included Mann-Whitney U test and χ2 tests, with a significance level.

Result(s)

During minimal COS treatment, most subjects did not experience breast swelling (86%), pelvic or abdominal pain (76%), nausea or vomiting (96%), and bleeding (96%). After oocyte pick-up, the majority (75%) reported no pelvic or abdominal pain. The most common side effect was abdominal swelling (52%). Compared with conventional COS cycles, minimal COS subjects reported significantly less postretrieval pain, with 33% experiencing no pain (vs. 6%) and with a reduced severe level of pain (5% vs. 19%), leading to fewer subjects requiring pain medication (25% vs. 54%). Additionally, 85% of women were very satisfied with minimal stimulation treatment and would recommend or repeat the treatment.

Conclusion(s)

Reducing the hormonal dose for ovarian stimulation has a beneficial effect on subjects, suggesting the combination of minimal COS treatment with IVM techniques is a well-tolerated alternative for women who cannot or do not wish to undergo conventionally controlled ovarian hyperstimulation treatment.

目的:评估体外成熟(IVM)中最小控制卵巢刺激(COS)下的卵母细胞获取经验和副作用:评估体外成熟(IVM)中最小控制卵巢刺激(COS)与传统 COS 相比的卵母细胞获取经验和副作用:设计:回顾性调查研究研究对象:西班牙临床体外受精(IVF)治疗中心:数据收集自2022年4月至2023年11月接受最小COS(n=110;600-800 IU FSH)体外受精和常规COS捐卵(n=48;1800-2600 IU FSH)的受试者:主要结果指标:卵巢刺激过程中和OPU后最常见的副作用、满意度以及推荐或重复最小或常规COS的可能性。统计分析包括曼-惠特尼检验和卡方检验,显著性水平设定为 p结果:在最小 COS 过程中,大多数受试者没有出现乳房胀痛(86%)、盆腔或腹痛(76%)、恶心或呕吐(96%)和出血(96%)。取卵后,大多数受试者(75%)没有出现盆腔或腹部疼痛。最常见的副作用是腹部肿胀(52%)。与传统的 COS 周期相比,最小 COS 受试者报告的取卵后疼痛明显减少,33% 的受试者没有疼痛感(对 6%;P=0.0011),剧烈疼痛程度降低(5% 对 19%;P=0.0097),需要服用止痛药的受试者减少(25% 对 54%;P=0.0003)。此外,85%的妇女对最小刺激非常满意,并愿意推荐或重复这种治疗方法:结论:减少卵巢刺激的激素剂量对受试者有好处,这表明对于不能或不愿接受常规控制性卵巢过度刺激的妇女来说,将最小COS与IVM技术相结合是一种耐受性良好的替代方法。
{"title":"Donor side effects experienced under minimal controlled ovarian stimulation with in vitro maturation vs. conventional controlled ovarian stimulation for in vitro fertilization treatment","authors":"","doi":"10.1016/j.xfss.2024.05.002","DOIUrl":"10.1016/j.xfss.2024.05.002","url":null,"abstract":"<div><h3>Objective</h3><p>To evaluate oocyte retrieval experiences and side effects under minimally controlled ovarian stimulation (COS) treatment for in vitro maturation (IVM) of oocytes compared with conventional COS treatment.</p></div><div><h3>Design</h3><p>A retrospective survey study.</p></div><div><h3>Setting</h3><p>Clinical in vitro fertilization treatment center.</p></div><div><h3>Patient(s)</h3><p>Data were collected from subjects undergoing minimal COS treatment (n = 110; 600–800 IU follicle-stimulating hormone) for IVM of oocytes and conventional COS treatment for egg donation (n = 48; 1,800–2,600 IU follicle-stimulating hormone) from April 2022 to November 2023.</p></div><div><h3>Intervention(s)</h3><p>Minimal and conventional COS treatments.</p></div><div><h3>Main Outcome Measure(s)</h3><p>The most common side effects experienced during ovarian stimulation and after oocyte pick-up, satisfaction level, and the likelihood of recommending or repeating minimal or conventional COS. Statistical analysis included Mann-Whitney <em>U</em> test and χ<sup>2</sup> tests, with a significance level.</p></div><div><h3>Result(s)</h3><p>During minimal COS treatment, most subjects did not experience breast swelling (86%), pelvic or abdominal pain (76%), nausea or vomiting (96%), and bleeding (96%). After oocyte pick-up, the majority (75%) reported no pelvic or abdominal pain. The most common side effect was abdominal swelling (52%). Compared with conventional COS cycles, minimal COS subjects reported significantly less postretrieval pain, with 33% experiencing no pain (vs. 6%) and with a reduced severe level of pain (5% vs. 19%), leading to fewer subjects requiring pain medication (25% vs. 54%). Additionally, 85% of women were very satisfied with minimal stimulation treatment and would recommend or repeat the treatment.</p></div><div><h3>Conclusion(s)</h3><p>Reducing the hormonal dose for ovarian stimulation has a beneficial effect on subjects, suggesting the combination of minimal COS treatment with IVM techniques is a well-tolerated alternative for women who cannot or do not wish to undergo conventionally controlled ovarian hyperstimulation treatment.</p></div>","PeriodicalId":73012,"journal":{"name":"F&S science","volume":"5 3","pages":"Pages 242-251"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666335X24000296/pdfft?md5=f71ef9ef35ce3a99702aba69414b9ed3&pid=1-s2.0-S2666335X24000296-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141263469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reviewer of the Year 2023: F&S Science celebrates excellence in our world-class reviewers 年度评论员
Pub Date : 2024-08-01 DOI: 10.1016/j.xfss.2024.07.001
{"title":"Reviewer of the Year 2023: F&S Science celebrates excellence in our world-class reviewers","authors":"","doi":"10.1016/j.xfss.2024.07.001","DOIUrl":"10.1016/j.xfss.2024.07.001","url":null,"abstract":"","PeriodicalId":73012,"journal":{"name":"F&S science","volume":"5 3","pages":"Page 214"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141581715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comparison of obstetric and neonatal outcomes in polycystic ovary syndrome and congenital adrenal hyperplasia: a retrospective analysis of a population database 多囊卵巢综合征与 CAH 的产科和新生儿预后比较:对人口数据库的回顾性分析
Pub Date : 2024-08-01 DOI: 10.1016/j.xfss.2024.05.001

Objective

To investigate potential differences in pregnancy, delivery, and neonatal outcomes between 2 hyperandrogenic conditions in reproductive-aged women: polycystic ovary syndrome (PCOS) and congenital adrenal hyperplasia (CAH).

Design

Retrospective population-based study with data from the Health Care Cost and Utilization Project-Nationwide Inpatient Sample Database from 2004–2014.

Setting

Not applicable.

Patient(s)

A total of 14,881 women with PCOS and 298 women with CAH.

Intervention(s)

Not applicable.

Main Outcome Measure(s)

Gestational diabetes mellitus, placenta previa, pregnancy-induced hypertension (HTN), gestational HTN, preeclampsia, eclampsia, preeclampsia and eclampsia superimposed on HTN, preterm birth, preterm premature rupture of membrane, abruptio placenta, chorioamnionitis, mode of delivery, maternal infection, hysterectomy, blood transfusion, venous thromboembolism (deep vein thrombosis and pulmonary embolism during pregnancy, intrapartum, or postpartum), maternal death, chorioamnionitis, septicemia during labor, postpartum endometritis, septic pelvic, peritonitis, small for gestational age, congenital anomalies, and intrauterine fetal demise.

Result(s)

After adjusting for potential confounders, we found that women with PCOS were at increased risk of developing pregnancy-induced HTN (adjusted odds ratio [OR] = 1.76; 95% confidence interval [CI]: 1.12–2.77) and gestational diabetes (adjusted OR = 1.68; 95% CI: 1.12–2.52) when compared with women with CAH. Contrary women with CAH were at increased risk for delivery via cesarean section (adjusted OR = 0.59; 95% CI: 0.44–0.80) and small for gestational age neonates (adjusted OR = 0.32; 95% CI: 0.20–0.52).

Conclusion(s)

To our knowledge, this study is the first to directly compare obstetric and neonatal outcomes between patients with PCOS and CAH. Despite the similar phenotypes and some common hormonal and biochemical profiles, such as insulin resistance, hyperinsulinemia, and hyperandrogenism, our results suggest the existence of additional metabolic pathways implicated in the pathogenesis of pregnancy complications.

目的 探讨多囊卵巢综合征(PCOS)和先天性肾上腺皮质增生症(CAH)这两种育龄妇女高雄激素症在妊娠、分娩和新生儿结局方面的潜在差异。设计以人群为基础的回顾性研究,数据来自2004-2014年的医疗成本和利用项目--全国住院患者样本数据库。主要结果指标:妊娠糖尿病、前置胎盘、妊娠诱发高血压(HTN)、妊娠高血压、子痫前期、子痫、子痫前期和子痫叠加高血压、早产、早产胎膜早破、胎盘早剥、绒毛膜羊膜炎、分娩方式、产妇感染、输血、静脉血栓栓塞(孕期、产中或产后的深静脉血栓和肺栓塞)、产妇死亡、绒毛膜羊膜炎、分娩期败血症、产后子宫内膜炎、化脓性盆腔炎、腹膜炎、胎龄小、先天性畸形和胎儿宫内死亡。研究结果:在对潜在的混杂因素进行调整后,我们发现与患有CAH的妇女相比,患有多囊卵巢综合征的妇女罹患妊娠诱发高血压(调整后比值比[OR]=1.76;95%置信区间[CI]:1.12-2.77)和妊娠糖尿病(调整后比值比[OR]=1.68;95%置信区间[CI]:1.12-2.52)的风险更高。与此相反,CAH 女性通过剖宫产分娩(调整后 OR = 0.59;95% CI:0.44-0.80)和小胎龄新生儿(调整后 OR = 0.32;95% CI:0.20-0.52)的风险增加。尽管表型相似且存在一些共同的激素和生化特征,如胰岛素抵抗、高胰岛素血症和高雄激素,但我们的研究结果表明,在妊娠并发症的发病机制中还存在其他代谢途径。
{"title":"A comparison of obstetric and neonatal outcomes in polycystic ovary syndrome and congenital adrenal hyperplasia: a retrospective analysis of a population database","authors":"","doi":"10.1016/j.xfss.2024.05.001","DOIUrl":"10.1016/j.xfss.2024.05.001","url":null,"abstract":"<div><h3>Objective</h3><p>To investigate potential differences in pregnancy, delivery, and neonatal outcomes between 2 hyperandrogenic conditions in reproductive-aged women: polycystic ovary syndrome (PCOS) and congenital adrenal hyperplasia (CAH).</p></div><div><h3>Design</h3><p>Retrospective population-based study with data from the Health Care Cost and Utilization Project-Nationwide Inpatient Sample Database from 2004–2014.</p></div><div><h3>Setting</h3><p>Not applicable.</p></div><div><h3>Patient(s)</h3><p>A total of 14,881 women with PCOS and 298 women with CAH.</p></div><div><h3>Intervention(s)</h3><p>Not applicable.</p></div><div><h3>Main Outcome Measure(s)</h3><p>Gestational diabetes mellitus, placenta previa, pregnancy-induced hypertension (HTN), gestational HTN, preeclampsia, eclampsia, preeclampsia and eclampsia superimposed on HTN, preterm birth, preterm premature rupture of membrane, abruptio placenta, chorioamnionitis, mode of delivery, maternal infection, hysterectomy, blood transfusion, venous thromboembolism (deep vein thrombosis and pulmonary embolism during pregnancy, intrapartum, or postpartum), maternal death, chorioamnionitis, septicemia during labor, postpartum endometritis, septic pelvic, peritonitis, small for gestational age, congenital anomalies, and intrauterine fetal demise.</p></div><div><h3>Result(s)</h3><p>After adjusting for potential confounders, we found that women with PCOS were at increased risk of developing pregnancy-induced HTN (adjusted odds ratio [OR] = 1.76; 95% confidence interval [CI]: 1.12–2.77) and gestational diabetes (adjusted OR = 1.68; 95% CI: 1.12–2.52) when compared with women with CAH. Contrary women with CAH were at increased risk for delivery via cesarean section (adjusted OR = 0.59; 95% CI: 0.44–0.80) and small for gestational age neonates (adjusted OR = 0.32; 95% CI: 0.20–0.52).</p></div><div><h3>Conclusion(s)</h3><p>To our knowledge, this study is the first to directly compare obstetric and neonatal outcomes between patients with PCOS and CAH. Despite the similar phenotypes and some common hormonal and biochemical profiles, such as insulin resistance, hyperinsulinemia, and hyperandrogenism, our results suggest the existence of additional metabolic pathways implicated in the pathogenesis of pregnancy complications.</p></div>","PeriodicalId":73012,"journal":{"name":"F&S science","volume":"5 3","pages":"Pages 293-300"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666335X24000284/pdfft?md5=6dad6783275a10ecbc45dd50837e39dc&pid=1-s2.0-S2666335X24000284-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141140730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
F&S science
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1